Vor Biopharma Inc., a biotechnology firm specializing in biological products, has announced a significant adjustment to the exercise prices of certain stock options. On Monday, the company's board of ...

14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq ... of the Company's initial public offering, including the exercise of the over-allotment, totaled $6.9 million ...

14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq ... Gross proceeds of the Company's initial public offering, including the exercise of the over-allotment, totaled $6.9 ...

14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq ... Gross proceeds of the Company's initial public offering, including the exercise of the over-allotment, totaled $6.9 ...